Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Patient and control sample recovery may be decreased with the online dat amphetamines ii reagent (lot number 654236-01) when used on the cobas integra 400 and 800 series analysers. the affected lot shows reduced d-amphetamine cross-reactivity for higner concentrated d-amphetamine samples.